135 related articles for article (PubMed ID: 2447625)
21. [Tumor markers in malignancies of the gastrointestinal tract].
von Kleist S; Hohneck A
Internist (Berl); 1982 Jan; 23(1):10-2. PubMed ID: 6175599
[No Abstract] [Full Text] [Related]
22. [Clinical significance of present tumor markers].
Ohkura H
Gan To Kagaku Ryoho; 1993 May; 20(7):843-9. PubMed ID: 7683865
[TBL] [Abstract][Full Text] [Related]
23. [The value of tumor markers (among which carcinoembryonal antigen) in the diagnosis of malignant tumors in the gastrointestinal tract].
Wobbes T; Thomas CM; Segers MF
Ned Tijdschr Geneeskd; 1993 May; 137(20):995-9. PubMed ID: 7685066
[No Abstract] [Full Text] [Related]
24. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms].
Ławicki S; Mroczko B; Szmitkowski M
Postepy Hig Med Dosw; 2002; 56(5):617-34. PubMed ID: 12596691
[TBL] [Abstract][Full Text] [Related]
25. Radioimmunodiagnosis and radioimmunotherapy, 1982.
Sfakianakis GN; DeLand FH
J Nucl Med; 1982 Sep; 23(9):840-50. PubMed ID: 6180154
[No Abstract] [Full Text] [Related]
26. [Tumor markers in gastrointestinal cancer].
Shimano T; Monden T; Oji Y; Morimoto H; Tomita N; Mori T
Rinsho Byori; 1985 Aug; 33(8):853-60. PubMed ID: 3908746
[No Abstract] [Full Text] [Related]
27. [Differential cytology of effusions using monoclonal antibodies].
Lüttges J; Neumann K; Pflüger KH; Schmitz-Moormann P
Pathologe; 1988 May; 9(3):137-42. PubMed ID: 2457213
[No Abstract] [Full Text] [Related]
28. [Clinical significance of the circulating tumor-associated antigen CA 19-9 in cancers of the digestive tract].
Staab HJ; Hornung A; Anderer FA; Kieninger G
Dtsch Med Wochenschr; 1984 Jul; 109(30):1141-7. PubMed ID: 6204834
[TBL] [Abstract][Full Text] [Related]
29. [Tissue polypeptide antigen (TPA) as a tumor marker in disorders of the digestive tract: comparison with CEA].
Piantino P; Tappero G; Cerchier A; Pecchio F; Tridico F; Cattaneo U
Minerva Med; 1986 Apr; 77(16):617-20. PubMed ID: 3703360
[TBL] [Abstract][Full Text] [Related]
30. [Tumor antigens in gastroenterology (summary of session)].
Z Gastroenterol Verh; 1976; (12):172-88. PubMed ID: 73290
[No Abstract] [Full Text] [Related]
31. Clinical significance of serum CA125 values in patients with cancers of the digestive system.
Haga Y; Sakamoto K; Egami H; Yoshimura R; Mori K; Akagi M
Am J Med Sci; 1986 Jul; 292(1):30-4. PubMed ID: 3459357
[TBL] [Abstract][Full Text] [Related]
32. [The concentration of carcinoembryonic antigen and carbohydrate antigen Ca-19-9 in the blood serum in cancerous diseases of the gastrointestinal tract].
Mit'kov VV; Ogneva TV; Goriaĭnova II; Milanov S; Milkov V
Med Radiol (Mosk); 1989 Nov; 34(11):22-4. PubMed ID: 2586258
[TBL] [Abstract][Full Text] [Related]
33. [CA-19-9, CA50 and CEA in pancreatic and gastrointestinal tumors. Comparative studies].
Dienst C; Clodius T; Oldörp T; Uhlenbruck G; Diehl V
Med Klin (Munich); 1987 Jan; 82(2):45-50. PubMed ID: 3470595
[No Abstract] [Full Text] [Related]
34. [Clinical evaluation of tumor markers in patients with colorectal cancer].
Naritaka Y; Ogawa K; Matsumoto N; Hosokawa T; Kikuchi T; Koyama N; Haga S; Kajiwara T; Sakakibara N
Gan No Rinsho; 1987 Aug; 33(10):1274-80. PubMed ID: 2444727
[TBL] [Abstract][Full Text] [Related]
35. [The value of tumor markers in digestive oncology].
Ychou M; Rougier P; Bidart JM; Bellet D; Tigaud JM; Bohuon C
Ann Chir; 1989; 43(7):517-23. PubMed ID: 2694905
[TBL] [Abstract][Full Text] [Related]
36. [Prediction of recurrence of gastrointestinal cancer from standpoint of biological malignancies--tumor marker doubling time and its a half life period line].
Mai M; Takahashi Y
Hum Cell; 1993 Jun; 6(2):82-7. PubMed ID: 7692953
[TBL] [Abstract][Full Text] [Related]
37. [Introduction of a new laboratory marker for cancer of the pancreas (CA 19.9). Current experience].
Nunes AP; Jukemura J; Machado MC; Scheinberg MA
Rev Paul Med; 1986; 104(2):99-101. PubMed ID: 3468583
[No Abstract] [Full Text] [Related]
38. [Comparative study of the role of CA 19-9, CA 72-4 and CEA tumor antigens in the diagnosis of pancreatic cancer and other gastrointestinal malignant diseases].
Czakó L; Takács T; Babarczy E; Dux L; Lonovics J
Orv Hetil; 1997 Nov; 138(47):2981-5. PubMed ID: 9432648
[TBL] [Abstract][Full Text] [Related]
39. Tumour markers in gastrointestinal cancer.
Wahren B; Harmenberg U
Scand J Clin Lab Invest Suppl; 1991; 206():21-7. PubMed ID: 1947757
[No Abstract] [Full Text] [Related]
40. [New clinical tests: current status of tumor markers].
Imai K; Taniuchi A
Nihon Naika Gakkai Zasshi; 1993 Apr; 82(4):554-7. PubMed ID: 7688018
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
